Loading…

Smoking status among cancer patients by specialty: A U.S. nationwide representative analysis

Background Persistence in tobacco use among cancer survivors has been associated with a multitude of clinicodemographic factors. However, there is a paucity of understanding regarding the role the healthcare professional's specialty plays in tobacco cessation in tobacco‐related cancer survivors...

Full description

Saved in:
Bibliographic Details
Published in:Cancer medicine (Malden, MA) MA), 2023-12, Vol.12 (23), p.21389-21399
Main Authors: Nolazco, José Ignacio, Tang, Yuzhe, Alkhatib, Khalid Y., King, Andrew J., Mossanen, Matthew, Chang, Steven Lee
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 21399
container_issue 23
container_start_page 21389
container_title Cancer medicine (Malden, MA)
container_volume 12
creator Nolazco, José Ignacio
Tang, Yuzhe
Alkhatib, Khalid Y.
King, Andrew J.
Mossanen, Matthew
Chang, Steven Lee
description Background Persistence in tobacco use among cancer survivors has been associated with a multitude of clinicodemographic factors. However, there is a paucity of understanding regarding the role the healthcare professional's specialty plays in tobacco cessation in tobacco‐related cancer survivors. Methods We conducted a cross‐sectional analysis of data from cancer survivors with a smoking history using the Behavioral Risk Factor Surveillance System (BRFSS) database to examine differences in the proportion of patients continuing tobacco use among patients with a diagnosis of cancer segregated by cancer site specialty over the 2016–2020 period. We accounted for complex survey design and used sampling weights to obtain a nationwide representative sample. We employed modified Poisson regression adjusting for age, gender, education, income, race, marital status, and medical specialty. Results We analyzed 19,855 cancer survivors with a current or past history of tobacco use, of whom 5222 (26,3%) self‐reported to be current smokers. Patients with urological and gynecological tobacco‐related malignancies had a higher relative risk (RR) of being current smokers with a RR of 1.30 (95% confidence interval, 1.12–1.51) and 1.25 (95% confidence interval, 1.12–1.39) respectively. Malignant Hematology had the lowest RR of smoking status among all other specialties RR 0.85 (95% confidence interval, 0.59–1.21). Conclusions Continuing smoking rates among tobacco‐related cancer survivors were different between specialties. One in four cancer survivors were current smokers; this emphasizes health professionals' paramount role in tobacco cessation counseling. This study analyzed data from cancer survivors with a smoking history using the BRFSS database to examine differences in the proportion of patients continuing tobacco use among patients with a diagnosis of cancer segregated by cancer site specialty over the 2016–2020 period. Results showed that patients with urological and gynecological tobacco‐related malignancies had a higher relative risk of being current smokers, while malignant hematology had the lowest relative risk. The study concludes that continuing smoking rates among tobacco‐related cancer survivors differ between specialties and highlights the importance of health professionals in tobacco cessation counseling.
doi_str_mv 10.1002/cam4.6684
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10726820</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2892269003</sourcerecordid><originalsourceid>FETCH-LOGICAL-p3424-812e54886088bcd93f0acd3882a9bc09d5d60b32551a723847f7c81635e9547b3</originalsourceid><addsrcrecordid>eNpVUctOwzAQtBCIVqUHfgD5yKWpYzu2wwVVFS-piEPpDclyHLcY8iJOWuXvcdRSlb3seGc0a-0AcB2iIEQIT7XKacCYoGdgiBGNJpwRen6CB2Ds3BfyxRFmPLwEA8JjwTwcgo9lXn7bYgNdo5rWQZWX_qFVoU0NK9VYUzQOJh10ldFWZU13B2dwFSwDWHi2LHY2NbA2VW2cl_rR1kBVqKxz1l2Bi7XKnBkf-gisHh_e58-TxdvTy3y2mFSEYjoRITYRFYIhIRKdxmSNlE6JEFjFiUZxGqUMJQRHUag4JoLyNdciZCQycUR5Qkbgfu9btUluUu0_UqtMVrXNVd3JUln5nynsp9yUWxkijpnAyDvcHhzq8qc1rpG5ddpkmSpM2TqJRYwxixEiXnpzuuy45e-mXjDdC3Y2M92RD5Hs85J9XrLPS85nr7QH5Be194gA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2892269003</pqid></control><display><type>article</type><title>Smoking status among cancer patients by specialty: A U.S. nationwide representative analysis</title><source>Wiley-Blackwell Open Access Collection</source><source>PMC (PubMed Central)</source><source>Publicly Available Content (ProQuest)</source><creator>Nolazco, José Ignacio ; Tang, Yuzhe ; Alkhatib, Khalid Y. ; King, Andrew J. ; Mossanen, Matthew ; Chang, Steven Lee</creator><creatorcontrib>Nolazco, José Ignacio ; Tang, Yuzhe ; Alkhatib, Khalid Y. ; King, Andrew J. ; Mossanen, Matthew ; Chang, Steven Lee</creatorcontrib><description>Background Persistence in tobacco use among cancer survivors has been associated with a multitude of clinicodemographic factors. However, there is a paucity of understanding regarding the role the healthcare professional's specialty plays in tobacco cessation in tobacco‐related cancer survivors. Methods We conducted a cross‐sectional analysis of data from cancer survivors with a smoking history using the Behavioral Risk Factor Surveillance System (BRFSS) database to examine differences in the proportion of patients continuing tobacco use among patients with a diagnosis of cancer segregated by cancer site specialty over the 2016–2020 period. We accounted for complex survey design and used sampling weights to obtain a nationwide representative sample. We employed modified Poisson regression adjusting for age, gender, education, income, race, marital status, and medical specialty. Results We analyzed 19,855 cancer survivors with a current or past history of tobacco use, of whom 5222 (26,3%) self‐reported to be current smokers. Patients with urological and gynecological tobacco‐related malignancies had a higher relative risk (RR) of being current smokers with a RR of 1.30 (95% confidence interval, 1.12–1.51) and 1.25 (95% confidence interval, 1.12–1.39) respectively. Malignant Hematology had the lowest RR of smoking status among all other specialties RR 0.85 (95% confidence interval, 0.59–1.21). Conclusions Continuing smoking rates among tobacco‐related cancer survivors were different between specialties. One in four cancer survivors were current smokers; this emphasizes health professionals' paramount role in tobacco cessation counseling. This study analyzed data from cancer survivors with a smoking history using the BRFSS database to examine differences in the proportion of patients continuing tobacco use among patients with a diagnosis of cancer segregated by cancer site specialty over the 2016–2020 period. Results showed that patients with urological and gynecological tobacco‐related malignancies had a higher relative risk of being current smokers, while malignant hematology had the lowest relative risk. The study concludes that continuing smoking rates among tobacco‐related cancer survivors differ between specialties and highlights the importance of health professionals in tobacco cessation counseling.</description><identifier>ISSN: 2045-7634</identifier><identifier>EISSN: 2045-7634</identifier><identifier>DOI: 10.1002/cam4.6684</identifier><identifier>PMID: 37986671</identifier><language>eng</language><publisher>United States: John Wiley and Sons Inc</publisher><subject>cancer survivors ; physicians ; smoking cessation ; tobacco</subject><ispartof>Cancer medicine (Malden, MA), 2023-12, Vol.12 (23), p.21389-21399</ispartof><rights>2023 The Authors. published by John Wiley &amp; Sons Ltd.</rights><rights>2023 The Authors. Cancer Medicine published by John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-0239-6542 ; 0000-0002-7038-5861 ; 0000-0002-3043-0541 ; 0000-0001-5444-2515 ; 0000-0002-6008-0503</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10726820/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10726820/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,27924,27925,37013,46052,46476,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37986671$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nolazco, José Ignacio</creatorcontrib><creatorcontrib>Tang, Yuzhe</creatorcontrib><creatorcontrib>Alkhatib, Khalid Y.</creatorcontrib><creatorcontrib>King, Andrew J.</creatorcontrib><creatorcontrib>Mossanen, Matthew</creatorcontrib><creatorcontrib>Chang, Steven Lee</creatorcontrib><title>Smoking status among cancer patients by specialty: A U.S. nationwide representative analysis</title><title>Cancer medicine (Malden, MA)</title><addtitle>Cancer Med</addtitle><description>Background Persistence in tobacco use among cancer survivors has been associated with a multitude of clinicodemographic factors. However, there is a paucity of understanding regarding the role the healthcare professional's specialty plays in tobacco cessation in tobacco‐related cancer survivors. Methods We conducted a cross‐sectional analysis of data from cancer survivors with a smoking history using the Behavioral Risk Factor Surveillance System (BRFSS) database to examine differences in the proportion of patients continuing tobacco use among patients with a diagnosis of cancer segregated by cancer site specialty over the 2016–2020 period. We accounted for complex survey design and used sampling weights to obtain a nationwide representative sample. We employed modified Poisson regression adjusting for age, gender, education, income, race, marital status, and medical specialty. Results We analyzed 19,855 cancer survivors with a current or past history of tobacco use, of whom 5222 (26,3%) self‐reported to be current smokers. Patients with urological and gynecological tobacco‐related malignancies had a higher relative risk (RR) of being current smokers with a RR of 1.30 (95% confidence interval, 1.12–1.51) and 1.25 (95% confidence interval, 1.12–1.39) respectively. Malignant Hematology had the lowest RR of smoking status among all other specialties RR 0.85 (95% confidence interval, 0.59–1.21). Conclusions Continuing smoking rates among tobacco‐related cancer survivors were different between specialties. One in four cancer survivors were current smokers; this emphasizes health professionals' paramount role in tobacco cessation counseling. This study analyzed data from cancer survivors with a smoking history using the BRFSS database to examine differences in the proportion of patients continuing tobacco use among patients with a diagnosis of cancer segregated by cancer site specialty over the 2016–2020 period. Results showed that patients with urological and gynecological tobacco‐related malignancies had a higher relative risk of being current smokers, while malignant hematology had the lowest relative risk. The study concludes that continuing smoking rates among tobacco‐related cancer survivors differ between specialties and highlights the importance of health professionals in tobacco cessation counseling.</description><subject>cancer survivors</subject><subject>physicians</subject><subject>smoking cessation</subject><subject>tobacco</subject><issn>2045-7634</issn><issn>2045-7634</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNpVUctOwzAQtBCIVqUHfgD5yKWpYzu2wwVVFS-piEPpDclyHLcY8iJOWuXvcdRSlb3seGc0a-0AcB2iIEQIT7XKacCYoGdgiBGNJpwRen6CB2Ds3BfyxRFmPLwEA8JjwTwcgo9lXn7bYgNdo5rWQZWX_qFVoU0NK9VYUzQOJh10ldFWZU13B2dwFSwDWHi2LHY2NbA2VW2cl_rR1kBVqKxz1l2Bi7XKnBkf-gisHh_e58-TxdvTy3y2mFSEYjoRITYRFYIhIRKdxmSNlE6JEFjFiUZxGqUMJQRHUag4JoLyNdciZCQycUR5Qkbgfu9btUluUu0_UqtMVrXNVd3JUln5nynsp9yUWxkijpnAyDvcHhzq8qc1rpG5ddpkmSpM2TqJRYwxixEiXnpzuuy45e-mXjDdC3Y2M92RD5Hs85J9XrLPS85nr7QH5Be194gA</recordid><startdate>202312</startdate><enddate>202312</enddate><creator>Nolazco, José Ignacio</creator><creator>Tang, Yuzhe</creator><creator>Alkhatib, Khalid Y.</creator><creator>King, Andrew J.</creator><creator>Mossanen, Matthew</creator><creator>Chang, Steven Lee</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0239-6542</orcidid><orcidid>https://orcid.org/0000-0002-7038-5861</orcidid><orcidid>https://orcid.org/0000-0002-3043-0541</orcidid><orcidid>https://orcid.org/0000-0001-5444-2515</orcidid><orcidid>https://orcid.org/0000-0002-6008-0503</orcidid></search><sort><creationdate>202312</creationdate><title>Smoking status among cancer patients by specialty: A U.S. nationwide representative analysis</title><author>Nolazco, José Ignacio ; Tang, Yuzhe ; Alkhatib, Khalid Y. ; King, Andrew J. ; Mossanen, Matthew ; Chang, Steven Lee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p3424-812e54886088bcd93f0acd3882a9bc09d5d60b32551a723847f7c81635e9547b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>cancer survivors</topic><topic>physicians</topic><topic>smoking cessation</topic><topic>tobacco</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nolazco, José Ignacio</creatorcontrib><creatorcontrib>Tang, Yuzhe</creatorcontrib><creatorcontrib>Alkhatib, Khalid Y.</creatorcontrib><creatorcontrib>King, Andrew J.</creatorcontrib><creatorcontrib>Mossanen, Matthew</creatorcontrib><creatorcontrib>Chang, Steven Lee</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>Wiley-Blackwell Backfiles (Open access)</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer medicine (Malden, MA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nolazco, José Ignacio</au><au>Tang, Yuzhe</au><au>Alkhatib, Khalid Y.</au><au>King, Andrew J.</au><au>Mossanen, Matthew</au><au>Chang, Steven Lee</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Smoking status among cancer patients by specialty: A U.S. nationwide representative analysis</atitle><jtitle>Cancer medicine (Malden, MA)</jtitle><addtitle>Cancer Med</addtitle><date>2023-12</date><risdate>2023</risdate><volume>12</volume><issue>23</issue><spage>21389</spage><epage>21399</epage><pages>21389-21399</pages><issn>2045-7634</issn><eissn>2045-7634</eissn><abstract>Background Persistence in tobacco use among cancer survivors has been associated with a multitude of clinicodemographic factors. However, there is a paucity of understanding regarding the role the healthcare professional's specialty plays in tobacco cessation in tobacco‐related cancer survivors. Methods We conducted a cross‐sectional analysis of data from cancer survivors with a smoking history using the Behavioral Risk Factor Surveillance System (BRFSS) database to examine differences in the proportion of patients continuing tobacco use among patients with a diagnosis of cancer segregated by cancer site specialty over the 2016–2020 period. We accounted for complex survey design and used sampling weights to obtain a nationwide representative sample. We employed modified Poisson regression adjusting for age, gender, education, income, race, marital status, and medical specialty. Results We analyzed 19,855 cancer survivors with a current or past history of tobacco use, of whom 5222 (26,3%) self‐reported to be current smokers. Patients with urological and gynecological tobacco‐related malignancies had a higher relative risk (RR) of being current smokers with a RR of 1.30 (95% confidence interval, 1.12–1.51) and 1.25 (95% confidence interval, 1.12–1.39) respectively. Malignant Hematology had the lowest RR of smoking status among all other specialties RR 0.85 (95% confidence interval, 0.59–1.21). Conclusions Continuing smoking rates among tobacco‐related cancer survivors were different between specialties. One in four cancer survivors were current smokers; this emphasizes health professionals' paramount role in tobacco cessation counseling. This study analyzed data from cancer survivors with a smoking history using the BRFSS database to examine differences in the proportion of patients continuing tobacco use among patients with a diagnosis of cancer segregated by cancer site specialty over the 2016–2020 period. Results showed that patients with urological and gynecological tobacco‐related malignancies had a higher relative risk of being current smokers, while malignant hematology had the lowest relative risk. The study concludes that continuing smoking rates among tobacco‐related cancer survivors differ between specialties and highlights the importance of health professionals in tobacco cessation counseling.</abstract><cop>United States</cop><pub>John Wiley and Sons Inc</pub><pmid>37986671</pmid><doi>10.1002/cam4.6684</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-0239-6542</orcidid><orcidid>https://orcid.org/0000-0002-7038-5861</orcidid><orcidid>https://orcid.org/0000-0002-3043-0541</orcidid><orcidid>https://orcid.org/0000-0001-5444-2515</orcidid><orcidid>https://orcid.org/0000-0002-6008-0503</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-7634
ispartof Cancer medicine (Malden, MA), 2023-12, Vol.12 (23), p.21389-21399
issn 2045-7634
2045-7634
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10726820
source Wiley-Blackwell Open Access Collection; PMC (PubMed Central); Publicly Available Content (ProQuest)
subjects cancer survivors
physicians
smoking cessation
tobacco
title Smoking status among cancer patients by specialty: A U.S. nationwide representative analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A36%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Smoking%20status%20among%20cancer%20patients%20by%20specialty:%20A%20U.S.%20nationwide%20representative%20analysis&rft.jtitle=Cancer%20medicine%20(Malden,%20MA)&rft.au=Nolazco,%20Jos%C3%A9%20Ignacio&rft.date=2023-12&rft.volume=12&rft.issue=23&rft.spage=21389&rft.epage=21399&rft.pages=21389-21399&rft.issn=2045-7634&rft.eissn=2045-7634&rft_id=info:doi/10.1002/cam4.6684&rft_dat=%3Cproquest_pubme%3E2892269003%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p3424-812e54886088bcd93f0acd3882a9bc09d5d60b32551a723847f7c81635e9547b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2892269003&rft_id=info:pmid/37986671&rfr_iscdi=true